0 Σχόλια
0 Μοιράστηκε
164 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
- Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
- Rare Disease Diagnostics Market Growth Trends and Key Players AnalysisThe global rare disease diagnostics market, valued at USD 40,227.42 million in 2023, is projected to grow steadily from USD 43,872.03 million in 2024 to USD 88,969.27 million by 2032, registering a compound annual growth rate (CAGR) of 9.2% during the forecast period. Rising awareness, technological advancements in genetic testing, and government support for orphan disease research are driving...0 Σχόλια 0 Μοιράστηκε 169 Views 0 Προεπισκόπηση
- U.S Rare Disease Diagnostics Market Growth Trends and AnalysisThe U.S. rare disease diagnostics market, valued at USD 12,875.84 million in 2023, is expected to witness robust growth over the coming years. The market is projected to grow from USD 14,047.46 million in 2024 to USD 28,567.83 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.3% during the forecast period. This significant rise highlights the increasing demand for advanced...0 Σχόλια 0 Μοιράστηκε 153 Views 0 Προεπισκόπηση
- Europe Blood Screening Market Overview, Growth Analysis, Trends and Forecast By 2029"Comprehensive Outlook on Executive Summary Europe Blood Screening Market Size and Share Data Bridge Market Research analyses that the Europe blood screening market to be grow at a CAGR of 9.00% in the forecast period of 2022-2029. A competitive era calls for businesses to be equipped with acquaintance of the major happenings of the market and Europe Blood Screening Market industry. Being a...0 Σχόλια 0 Μοιράστηκε 22 Views 0 Προεπισκόπηση
- U.S Rare Disease Diagnostics Market Becoming a Catalyst for Technological ProgressMarket Overview The U.S. rare disease diagnostics market size was valued at USD 12,875.84 million in 2023. The market is anticipated to grow from USD 14,047.46 million in 2024 to USD 28,567.83 million by 2032, exhibiting a CAGR of 9.3% during the forecast period. Rare diseases, often characterized by their low prevalence, present unique challenges in diagnosis and treatment. The U.S. market for...0 Σχόλια 0 Μοιράστηκε 62 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων